-
Electronic (PDF)
-
1 - 5 Users
-
Enterprisewide
Global Veterinary Vaccines Market 2011-2015
Infiniti Research Limited, July 2012, Pages: 41
TechNavio's analysts forecast the Global Veterinary Vaccines market to grow at a CAGR of 12.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in prevalence of zoonotic diseases in humans. The Global Veterinary Vaccines market has also been witnessing a rise in contract manufacturing activities. However, the emergence of vaccine-resistant viruses could pose a challenge to the growth of this market.
TechNavio's report, the Global Veterinary Vaccines Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Livestock vaccines and Companion vaccines landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Eli Lilly and Co., Merck & Co. Inc., Pfizer Inc., and Sanofi S.A.
Other vendors mentioned in the report: AVANT Immunotherapeutics Inc., Embrex Inc., Bayer AG, Boehringer Ingelheim GmbH, Heska Corp., Imugene Ltd., Indian Immunologicals Ltd., Intervet International B.V., Lohmann Animal Health GmbH & Co. KG, Novartis AG, Protein Sciences Corp., Schering-Plough Corp., and Vibrac AH Inc.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio today launched its report Global Veterinary Vaccines Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; “The Global Veterinary Vaccines market offers plenty of growth opportunities for the vendors in the market because of the high demand for different veterinary vaccines that can counter infections and diseases worldwide. Since the market is lucrative, vendors are investing heavily in R&D activities to develop innovative vaccines. This has resulted in the introduction of new technologies such as DNA vaccine preparation, T-cell receptor peptide vaccine preparation, recombinant vector vaccine preparation, and immunogenic inactivated cell culture vaccine preparation.”
According to the report, to protect the animal population from life-threatening infections and diseases, the demand for veterinary vaccines has increased worldwide. Hence the increase in the sales of veterinary vaccines is acting as a driver for the growth of the Global Veterinary Vaccines market.
Further, the report also discusses that the development of vaccine-resistant viruses is another major challenge for the stakeholders in the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Products
04. Market Landscape
Global Veterinary Vaccines Market
Overall Market Size
Market Segmentation by Vaccine Category
Market Segmentation by Animal Category
04.1 Segmentation of Global Livestock Vaccines Market
04.2 Segmentation of Global Companion Vaccines Market
Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
US
China
Germany
07. Vendor Landscape
Vendor Ranking
Product Portfolio Matrix
Global Animal Health Products Market
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Pfizer Inc.
Business Overview
SWOT Analysis
14.2 Merck and Co. Inc.
Business Overview
SWOT Analysis
14.3 Sanofi S.A.
Business Overview
SWOT Analysis
14.4 Eli Lilly and Co.
Business Overview
SWOT Analysis
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Veterinary Vaccines Market by Product Segmentation
Exhibit 2: Global Veterinary Vaccines Market 2011-2015 (US$ billion)
Exhibit 3: Global Veterinary Vaccines Market Segmentation by Vaccine Category 2011
Exhibit 4: Global Veterinary Vaccines Market Segmentation by Animal Category 2011
Exhibit 5: Global Livestock Vaccines Market Segmentation by Animal Category 2011
Exhibit 6: Global Companion Vaccines Market Segmentation By Animal Category 2011
Exhibit 7: Global Veterinary Vaccines Market by Geographical Segmentation 2011
Exhibit 8: Global Animal Health Products Market by Vendor Segmentation 2011
Eli Lilly and Co., Merck & Co., Pfizer, Sanofi S.A
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
